{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:04:55Z","timestamp":1767092695982,"version":"3.40.5"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cbi.2024.111189","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:32:54Z","timestamp":1723095174000},"page":"111189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["3,3-Dibromoflavanone, a synthetic flavonoid derivative for pain management with antidepressant-like effects and fewer side effects than those of morphine in mice"],"prefix":"10.1016","volume":"402","author":[{"given":"Natalia","family":"Colettis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Wasowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-1384","authenticated-orcid":false,"given":"Damijan","family":"Knez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-1559","authenticated-orcid":false,"given":"Valentina","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0190-598X","authenticated-orcid":false,"given":"Mariel","family":"Marder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2011","series-title":"Committee on Advancing Pain Research, Pain as a Public Health Challenge, en: Reli. Pain Am. A Bluepr. Transform. Prev. Care, Educ. Res.","key":"10.1016\/j.cbi.2024.111189_bib1"},{"key":"10.1016\/j.cbi.2024.111189_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000002557","article-title":"A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors","volume":"163","author":"Zimmer","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.cbi.2024.111189_bib3","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/j.1532-2149.2013.00334.x","article-title":"Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study","volume":"17","author":"Radat","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.cbi.2024.111189_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/14737167.6.5.591","article-title":"Economic burden of chronic pain","volume":"6","author":"Phillips","year":"2006","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.cbi.2024.111189_bib5","series-title":"A European consensus report, en","article-title":"Pain proposal: improving the current and future management of chronic pain","author":"Baker","year":"2010"},{"key":"10.1016\/j.cbi.2024.111189_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40122-020-00170-8","article-title":"Lessons for better pain management in the future: learning from the past","volume":"9","author":"Manchikanti","year":"2020","journal-title":"Pain Ther"},{"key":"10.1016\/j.cbi.2024.111189_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib8","first-page":"31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications, Anesth","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Prog."},{"year":"2022","series-title":"Morphine, StatPearls, Internet","author":"Murphy","key":"10.1016\/j.cbi.2024.111189_bib9"},{"key":"10.1016\/j.cbi.2024.111189_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/pmt.11.78","article-title":"Is morphine still the best reference opioid?","volume":"2","author":"G\u00e1lvez","year":"2012","journal-title":"Pain Manag."},{"key":"10.1016\/j.cbi.2024.111189_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctcp.2009.02.003","article-title":"Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics","volume":"15","author":"Hasan","year":"2009","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.cbi.2024.111189_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1476-5381.1972.tb06866.x","article-title":"Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment","volume":"46","author":"Babbini","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib13","first-page":"119","article-title":"New approaches to the treatment of opioid-induced constipation","volume":"1","author":"Holzer","year":"2008","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2024.111189_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00213-011-2432-z","article-title":"Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice","volume":"219","author":"Koek","year":"2012","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.cbi.2024.111189_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1756283X15578608","article-title":"Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities","volume":"8","author":"Nelson","year":"2015","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.cbi.2024.111189_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020349","article-title":"Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents","volume":"27","author":"Najmi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111189_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030762","article-title":"Therapeutic potential of flavonoids in pain and inflammation: mechanisms of action, pre-clinical and clinical data, and pharmaceutical development","volume":"25","author":"Ferraz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111189_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2007.11.011","article-title":"Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines","volume":"580","author":"Loscalzo","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib19","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.22197","article-title":"Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin","volume":"47","author":"Nahmias","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111189_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00253-005-0116-5","article-title":"Combinatorial biosynthesis of flavones and flavonols in Escherichia coli","volume":"71","author":"Miyahisa","year":"2006","journal-title":"Appl. Microbiol. Biotechnol."},{"year":"2005","series-title":"Flavonoids: Chemistry, Biochemistry and Applications","author":"Andersen","key":"10.1016\/j.cbi.2024.111189_bib21"},{"key":"10.1016\/j.cbi.2024.111189_bib22","first-page":"9","article-title":"Flavonoids as GABA A receptor ligands : the whole story","volume":"4","author":"Wasowski","year":"2012","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phymed.2017.12.032","article-title":"Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants","volume":"40","author":"Larit","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111189_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bioorg.2015.07.001","article-title":"Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: synthesis, biochemistry and molecular docking studies","volume":"62","author":"Mathew","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bmc.2009.12.029","article-title":"A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors","volume":"18","author":"Chimenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pnpbp.2007.07.023","article-title":"Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds","volume":"32","author":"Ognibene","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.cbi.2024.111189_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5762172","article-title":"Antidepressant flavonoids and their relationship with oxidative stress","volume":"2017","author":"Hritcu","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2024.111189_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.pnpbp.2007.12.021","article-title":"Antidepressant-like effects of liquiritin and isoliquiritin from Glycyrrhiza uralensis in the forced swimming test and tail suspension test in mice","volume":"32","author":"Wang","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.cbi.2024.111189_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168878","article-title":"Screening anti-inflammatory effects of flavanones solutions","volume":"22","author":"Bustos-Salgado","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111189_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-021-00959-y","article-title":"Flavonoids in the treatment of neuropathic pain","volume":"25","author":"Rao","year":"2021","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.cbi.2024.111189_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2013.04.020","article-title":"In vitro binding affinities of a series of flavonoids for \u03bc-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice","volume":"72","author":"Higgs","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2024.111189_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pbb.2011.05.018","article-title":"Hesperidin induces antinociceptive effect in mice and its aglycone, hesperetin, binds to \u03bc-opioid receptor and inhibits GIRK1\/2 currents","volume":"99","author":"Loscalzo","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"year":"1990","series-title":"New Hydrolase Substrates","author":"von der Eltz","key":"10.1016\/j.cbi.2024.111189_bib33"},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","key":"10.1016\/j.cbi.2024.111189_bib34"},{"key":"10.1016\/j.cbi.2024.111189_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bmc.2016.11.032","article-title":"N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: potential multifunctional anti-Alzheimer\u2019s agents","volume":"25","author":"Ko\u0161ak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib36","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/0006-2952(90)90716-X","article-title":"Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties","volume":"40","author":"Medina","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib37","article-title":"Modulation of [3H]-8-OH-DPAT binding to rat brain membranes by metal IONS","volume":"50","author":"Arro","year":"2001","journal-title":"Proc. Est. Acad. Sci. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib38","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2024.111189_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2024.111189_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/10550887.2011.609805","article-title":"Alternate routes of administration and risk for HIV among prescription opioid abusers","volume":"30","author":"Surratt","year":"2011","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.cbi.2024.111189_bib41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain--misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2024.111189_bib42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2006.04.004","article-title":"Central nervous system depressant action of flavonoid glycosides","volume":"539","author":"Fern\u00e1ndez","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-3057(77)90036-3","article-title":"A new device for the rapid measurement of impaired motor function in mice","volume":"6","author":"Coughenour","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.cbi.2024.111189_bib44","doi-asserted-by":"crossref","DOI":"10.3791\/2610-v","article-title":"Measuring the strength of mice","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.cbi.2024.111189_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","article-title":"Behavioral phenotyping of mice in pharmacological and toxicological research","volume":"55","author":"Karl","year":"2003","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2024.111189_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3959(91)90207-E","article-title":"Differentiating analgesic and non-analgesic drug activities on rat hot plate: effect of behavioral endpoint","volume":"47","author":"Carter","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.cbi.2024.111189_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0361-9230(02)00825-0","article-title":"The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms","volume":"58","author":"Schreiber","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cbi.2024.111189_bib48","article-title":"Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites","volume":"237","author":"Manara","year":"1986","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2024.111189_bib49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00501390","article-title":"Centrally and peripherally mediated inhibition of intestinal motility by opioids","volume":"308","author":"Schulz","year":"1979","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib50","first-page":"272","article-title":"Agresi\u00f3n y efectos condicionados en el s\u00edndrome de abstinencia a los opi\u00e1ceos","volume":"1","author":"Rodr\u00edguez-Arias","year":"1999","journal-title":"Trastor. Adict."},{"key":"10.1016\/j.cbi.2024.111189_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0278-5846(01)00277-9","article-title":"Ethological analysis of morphine withdrawal with different dependence programs in male mice","volume":"26","author":"Broseta","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.cbi.2024.111189_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(01)02655-5","article-title":"Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice","volume":"909","author":"Yamaguchi","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2024.111189_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.cbi.2024.111189_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\"Behavioural despair\" in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2024.111189_bib55","first-page":"1","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"71","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.111189_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3329\/bjp.v13i1.33625","article-title":"Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity","volume":"13","author":"Lohidashan","year":"2018","journal-title":"Bangladesh J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.cbi.2024.111189_bib58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"year":"2008","series-title":"Drug Discovery and Evaluation: Pharmacological Assays","author":"Vogel","key":"10.1016\/j.cbi.2024.111189_bib59"},{"author":"Bhargava","key":"10.1016\/j.cbi.2024.111189_bib60"},{"key":"10.1016\/j.cbi.2024.111189_bib61","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"8","author":"Castagn\u00e9","year":"2011","journal-title":"Curr. Protoc. Neurosci. Chapter"},{"key":"10.1016\/j.cbi.2024.111189_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2024.111189_bib63","article-title":"Serotonergic modulation of locomotor activity from basal vertebrates to mammals","volume":"14","author":"Flaive","year":"2020","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.cbi.2024.111189_bib64","article-title":"Attenuation and reversal of morphine tolerance by the competitive N- methyl-D-aspartate receptor antagonist, LY274614","volume":"264","author":"Tiseo","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2024.111189_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2017.09.022","article-title":"Opioid-induced rewards, locomotion, and dopamine activation: a proposed model for control by mesopontine and rostromedial tegmental neurons","volume":"83","author":"Steidl","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cbi.2024.111189_bib66","first-page":"251","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","author":"Trujillo","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cbi.2024.111189_bib67","doi-asserted-by":"crossref","DOI":"10.1159\/000096428","article-title":"Influence of morphine and dopamine receptor sensitization on locomotor activity in mice","volume":"78","author":"Heidari","year":"2006","journal-title":"Pharmacology"},{"key":"10.1016\/j.cbi.2024.111189_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/0306-3623(92)90315-B","article-title":"Morphine stimulates locomotor activity by an indirect dopaminergic mechanism: possible D-1 and D-2 receptor involvement","volume":"23","author":"Zarrindast","year":"1992","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib69","doi-asserted-by":"crossref","DOI":"10.1254\/jphs.FPJ04039X","article-title":"Combined effects of psychostimulants and morphine on locomotor activity in mice","volume":"96","author":"Mori","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2024.111189_bib70","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2024.111189_bib71","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-006-9087-x","article-title":"Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor","volume":"31","author":"Kitanaka","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2024.111189_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088516","article-title":"P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac","volume":"9","author":"Sanchez-Covarrubias","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2024.111189_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174302","article-title":"The mechanisms involved in morphine addiction: an overview","volume":"20","author":"Listos","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111189_bib74","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/bjp.2008.100","article-title":"Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction","volume":"154","author":"Christie","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib75","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/156802611795371288","article-title":"Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance","volume":"11","author":"Mercer","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(99)00599-8","article-title":"Increased brain P-glycoprotein in morphine tolerant rats","volume":"66","author":"Aquilante","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2024.111189_bib77","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/85115","article-title":"Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs","volume":"4","author":"King","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cbi.2024.111189_bib78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0009-9236(03)00220-0","article-title":"Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine","volume":"74","author":"Skarke","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2024.111189_bib79","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2024.111189_bib80","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1074\/jbc.272.2.782","article-title":"Differential opioid agonist regulation of the mouse \u03bc opioid receptor","volume":"272","author":"Blake","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(06)54001-3","article-title":"The role of GABA in the mediation and perception of pain","volume":"54","author":"Enna","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051735","article-title":"(-)-Naringenin 4\u2019,7-dimethyl ether isolated from nardostachys jatamansi relieves pain through inhibition of multiple channels","volume":"27","author":"Gu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111189_bib83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1152\/jn.00517.2021","article-title":"Pinocembrin relieves hip fracture-induced pain by repressing spinal substance P signaling in aged rats","volume":"127","author":"Xing","year":"2022","journal-title":"J. Neurophysiol."},{"author":"Deng","key":"10.1016\/j.cbi.2024.111189_bib84"},{"key":"10.1016\/j.cbi.2024.111189_bib85","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/mol.113.086843","article-title":"Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo","volume":"84","author":"Straub","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib86","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopha.2016.10.017","article-title":"6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain","volume":"84","author":"Akbar","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111189_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172972","article-title":"6-Methoxyflavanone abates cisplatin-induced neuropathic pain apropos anti-inflammatory mechanisms: a behavioral and molecular simulation study","volume":"872","author":"Akbar","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bja\/aen088","article-title":"Spinal cord mechanisms of pain","volume":"101","author":"D'Mello","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.cbi.2024.111189_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2017.02.047","article-title":"Characterization of 6-methoxyflavanone as a novel anxiolytic agent: a behavioral and pharmacokinetic approach","volume":"801","author":"Akbar","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111189_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00702-014-1362-4","article-title":"Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression","volume":"123","author":"Naoi","year":"2016","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.cbi.2024.111189_bib91","first-page":"498","article-title":"Monoamine oxidase as a target for drug action","volume":"60","author":"Drozak","year":"2006","journal-title":"Postep. Hig Med Dosw."},{"key":"10.1016\/j.cbi.2024.111189_bib92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12031-019-01366-0","article-title":"Cerebral MAO activity is not altered by a novel herbal antidepressant treatment","volume":"69","author":"Doron","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cbi.2024.111189_bib93","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.rpsm.2018.09.002","article-title":"Tianeptine, an atypical pharmacological approach to depression","volume":"12","author":"Alamo","year":"2019","journal-title":"Rev. Psiquiat\u00eda Salud Ment."},{"key":"10.1016\/j.cbi.2024.111189_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104800","article-title":"The opioid system in depression","volume":"140","author":"Jelen","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cbi.2024.111189_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.30","article-title":"The atypical antidepressant and neurorestorative agent tianeptine is a \u03bc-opioid receptor agonist","volume":"4","author":"Gassaway","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cbi.2024.111189_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02791072.2018.1438687","article-title":"Tianeptine abuse and dependence in psychiatric patients: a review of 18 case reports in the literature","volume":"50","author":"Springer","year":"2018","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.cbi.2024.111189_bib97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/15563650.2020.1781151","article-title":"Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health","volume":"59","author":"Rushton","year":"2021","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cbi.2024.111189_bib99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000484207","article-title":"Opioid receptors contribute to antinociceptive effect of tianeptine on colorectal distension-induced visceral pain in rats","volume":"101","author":"Bilge","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/j.cbi.2024.111189_bib100","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S1734-1140(11)70716-2","article-title":"NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice","volume":"63","author":"Wla\u017a","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2024.111189_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1186397","article-title":"Chronic tianeptine induces tolerance in analgesia and hyperlocomotion via mu-opioid receptor activation in mice","volume":"14","author":"Allain","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.cbi.2024.111189_bib102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pcn.12042","article-title":"Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy","volume":"67","author":"Woo","year":"2013","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.cbi.2024.111189_bib103","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1039\/D1MD00041A","article-title":"Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors","volume":"12","author":"De Neve","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.cbi.2024.111189_bib104","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T10:17:00Z","timestamp":1725877020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724003351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":103,"alternative-id":["S0009279724003351"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111189","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,3-Dibromoflavanone, a synthetic flavonoid derivative for pain management with antidepressant-like effects and fewer side effects than those of morphine in mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111189"}}